Results for "drug resistance"4

Showing 1–4 of 4 documents

Sorted by hybrid relevance (keyword + semantic via RRF)

GuidelineLTBI2018-02
Latent tuberculosis infection: updated and consolidated guidelines for programmatic management: annex 3: values and preferences for the management of latent tuberculosis infection: survey of populations affected by the recommendations
World Health Organization
GuidelineLTBI2018-02
Latent tuberculosis infection: updated and consolidated guidelines for programmatic management
World Health Organization

GuidelineLTBI2025-12Related document (Main document):

WHO updated recommendations on HIV clinical management: recommendations for a public health approach: web annex: supporting information

World Health Organization

…ghly effective for second-line therapy, while selected dual-drug regimens show comparable efficacy in specific populations. Long-acting injectable therapies demonstrate similar virological outcomes but raise concerns regarding resistance and adverse events. Evidence highlights t…

Results for "drug resistance"4

Latent tuberculosis infection: updated and consolidated guidelines for programmatic management: annex 3: values and preferences for the management of latent tuberculosis infection: survey of populations affected by the recommendations

Latent tuberculosis infection: updated and consolidated guidelines for programmatic management

Latent tuberculosis infection: updated and consolidated guidelines for programmatic management: annex 2: evidence-to-decision and GRADE tables

WHO updated recommendations on HIV clinical management: recommendations for a public health approach: web annex: supporting information